|
⚲
|
| Keyboard |
| Jensen Klavs F
✚
|
|
|---|---|
| CIK # | 0001829257 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001829257] | |
| 4 | [0001829257] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Jensen Klavs F | |
| SQZ Biotechnologies Co |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SQZ Biotechnologies Co SQZ
Stock Option · derivative
|
2023-06-14 | Grant | 39,875 | $0.00 | |
|
SQZ Biotechnologies Co SQZ
Stock Option · derivative
|
2022-06-15 | Grant | 20,000 | $0.00 | |
|
SQZ Biotechnologies Co SQZ
Common Stock
|
2022-05-25 | Buy | 14,326 | $3.52 | 50,428 |
|
SQZ Biotechnologies Co SQZ
Stock Option · derivative
|
2021-06-15 | Grant | 10,500 | $0.00 | |
|
SQZ Biotechnologies Co SQZ
Series B Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 6,908 | ||
|
SQZ Biotechnologies Co SQZ
Series Seed Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 7,017 | ||
|
SQZ Biotechnologies Co SQZ
Common Stock
|
2020-11-03 | Conversion | 14,662 | ||
|
SQZ Biotechnologies Co SQZ
Stock Option · derivative
|
2020-10-29 | Grant | 7,055 | $0.00 |